Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition

References

• Diehn M, Cho RW, and Clarke MF: Therapeutic implications of the cancer stem cell hypothesis. Semin Radiat Oncol 19, 78–86, 2009.
   PubMed Web of Science ®Google Scholar
• Visvader JE and Lindeman GJ: Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10, 717–728, 2012.
   PubMed Web of Science ®Google Scholar
• Luo M, Clouthier SG, Deol Y, Liu S, Nagrath S, et al.: Breast cancer stem cells: current advances and clinical implications. Methods Mol Biol 1293, 1–49, 2015.
   PubMedGoogle Scholar
• Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al.: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17, 1253–1270, 2003.
   PubMed Web of Science ®Google Scholar
• Pattabiraman DR and Weinberg RA: Tackling the cancer stem cells—what challenges do they pose? Nat Rev Drug Discov 13, 497–512, 2014.
   PubMed Web of Science ®Google Scholar
• Walia V and Elble RC: Enrichment for breast cancer cells with stem/progenitor properties by differential adhesion. Stem Cells Dev 19, 1175–1182, 2010.
   PubMed Web of Science ®Google Scholar
• Morata-Tarifa C, Jimenez G, Garcia MA, Entrena JM, Grinan-Lison C, et al.: Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells. Sci Rep 6, 18772–18783, 2016.
   PubMed Web of Science ®Google Scholar
• Tam WL, Lu H, Buikhuisen J, Soh BS, Lim E, et al.: Protein kinase C alpha is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell 24, 347–364, 2013.
   PubMed Web of Science ®Google Scholar
• Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715, 2008.
   PubMed Web of Science ®Google Scholar
• Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al.: Generation of breast cancer stem cells through epithelial-mesenchymal transition. Plos One 3, e2888, 2008.
   PubMed Web of Science ®Google Scholar
• Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, et al.: Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69, 2887–2895, 2009.
   PubMed Web of Science ®Google Scholar
• Li J and Zhou BP: Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 11, 49, 2011.
   PubMed Web of Science ®Google Scholar
• Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, et al.: FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res 73, 1981–1992, 2013.
   PubMed Web of Science ®Google Scholar
• Pattabiraman DR and Weinberg RA: Targeting the epithelial-to-mesenchymal transition: the case for differentiation-based therapy. Cold Spring Harb Symp Quant Biol 81, 11–19, 2017.
   Google Scholar
• Lansky EP and Newman RA: Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 109, 177–206, 2007.
   PubMed Web of Science ®Google Scholar
• Heber D: Pomegranate ellagitannins. In: Herbal Medicine: Biomolecular and Clinical Aspects, Benzie IFF and Wachtel-Galor S (Eds.). 2nd ed., Boca Raton: CRC Press, 2011, pp. 201–210.
   Google Scholar
• Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, and Kader AA: Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48, 4581–4589, 2000.
   PubMed Web of Science ®Google Scholar
• Seeram NP, Zhang Y, McKeever R, Henning SM, Lee RP, et al.: Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J Med Food 11, 390–394, 2008.
   PubMed Web of Science ®Google Scholar
• Syed DN, Chamcheu JC, Adhami VM, and Mukhtar H: Pomegranate extracts and cancer prevention: molecular and cellular activities. Anticancer Agents Med Chem 13, 1149–1161, 2013.
   PubMed Web of Science ®Google Scholar
• Turrini E, Ferruzzi L, and Fimognari C: Potential effects of pomegranate polyphenols in cancer prevention and therapy. Oxid Med Cell Longev 2015, 938475, 2015.
   PubMed Web of Science ®Google Scholar
• Kim ND, Mehta R, Yu W, Neeman I, Livney T, et al.: Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 71, 203–217, 2002.
   PubMed Web of Science ®Google Scholar
• Adams LS, Zhang Y, Seeram NP, Heber D, and Chen S: Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res (Phila) 3, 108–113, 2010.
   PubMed Web of Science ®Google Scholar
• Shirode AB, Kovvuru P, Chittur SV, Henning SM, Heber D, et al.: Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol Carcinog 53, 458–470, 2014.
   PubMed Web of Science ®Google Scholar
• Dai Z, Nair V, Khan M, and Ciolino HP: Pomegranate extract inhibits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in vitro. Oncol Rep 24, 1087–1091, 2010.
   PubMed Web of Science ®Google Scholar
• Banerjee N, Talcott S, Safe S, and Mertens-Talcott SU: Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res Treat 136, 21–34, 2012.
   PubMed Web of Science ®Google Scholar
• Bishayee A, Mandal A, Bhattacharyya P, and Bhatia D: Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis. Nutr Cancer 68, 120–130, 2016.
   PubMed Web of Science ®Google Scholar
• Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, et al.: Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr 136, 2481–2485, 2006.
   PubMed Web of Science ®Google Scholar
• Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, et al.: Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15, 50–65, 2001.
   PubMed Web of Science ®Google Scholar
• Kemmis CM and Welsh J: Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem 105, 980–988, 2008.
   PubMed Web of Science ®Google Scholar
• Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, et al.: CD44+/CD24− breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8, R59, 2006.
   PubMed Web of Science ®Google Scholar
• Borgna S, Armellin M, di Gennaro A, Maestro R, and Santarosa M: Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres. Cell Cycle 11, 4242–4251, 2012.
   PubMed Web of Science ®Google Scholar
• Kraus MH, Yuasa Y, and Aaronson SA: A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Proc Natl Acad Sci U S A 81, 5384–5388, 1984.
   PubMed Web of Science ®Google Scholar
• Dickson RB, Bates SE, McManaway ME, and Lippman ME: Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res 46, 1707–1713, 1986.
   PubMed Web of Science ®Google Scholar
• Yang TT, Sinai P, and Kain SR: An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells. Anal Biochem 241, 103–108, 1996.
   PubMed Web of Science ®Google Scholar
• Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al.: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65, 5506–5511, 2005.
   PubMed Web of Science ®Google Scholar
• Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, and Farrar WL: CD44+ CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98, 756–765, 2008.
   PubMed Web of Science ®Google Scholar
• Liang CC, Park AY, and Guan JL: In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2, 329–333, 2007.
   PubMed Web of Science ®Google Scholar
• Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, et al.: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122, 777–785, 2010.
   PubMed Web of Science ®Google Scholar
• Montales MT, Rahal OM, Kang J, Rogers TJ, Prior RL, et al.: Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells. Carcinogenesis 33, 652–660, 2012.
   PubMed Web of Science ®Google Scholar
• Fu Y, Chang H, Peng X, Bai Q, Yi L, et al.: Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/beta-catenin signaling pathway. Plos One 9, e102535, 2014.
   PubMed Web of Science ®Google Scholar
• Rocha A, Wang L, Penichet M, and Martins-Green M: Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer. Breast Cancer Res Treat 136, 647–658, 2012.
   PubMed Web of Science ®Google Scholar
• Wang L, Ho J, Glackin C, and Martins-Green M: Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl Oncol 5, 345–355, 2012.
   Web of Science ®Google Scholar
• Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, et al.: Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr Cancer Ther 8, 242–253, 2009.
   PubMed Web of Science ®Google Scholar
• Seino M, Okada M, Shibuya K, Seino S, Suzuki S, et al.: Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells. Anticancer Res 34, 4723–4731, 2014.
   PubMed Web of Science ®Google Scholar
• Yoon CH, Kim MJ, Kim RK, Lim EJ, Choi KS, et al.: c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells. Oncogene 31, 4655–4666, 2012.
   PubMed Web of Science ®Google Scholar
• Zhan X, Feng X, Kong Y, Chen Y, and Tan W: JNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1. BMC Cancer 13, 1–10, 2013.
   PubMed Web of Science ®Google Scholar
• Xu W, Yang Z, and Lu N: A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr 9, 317–324, 2015.
   PubMed Web of Science ®Google Scholar
• Cerda B, Espin JC, Parra S, Martinez P, and Tomas-Barberan FA: The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6 h-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr 43, 205–220, 2004.
   PubMed Web of Science ®Google Scholar
• Nunez-Sanchez MA, Karmokar A, Gonzalez-Sarrias A, Garcia-Villalba R, Tomas-Barberan FA, et al.: In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: a new potentiality for ellagitannin metabolites against cancer. Food Chem Toxicol 92, 8–16, 2016.
   PubMed Web of Science ®Google Scholar
• Paller CJ, Ye X, Wozniak PJ, Gillespie BK, Sieber PR, et al.: A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer Prostatic Dis 16, 50–55, 2013.
   PubMed Web of Science ®Google Scholar
• Pantuck AJ, Pettaway CA, Dreicer R, Corman J, Katz A, et al.: A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis 18, 242–248, 2015.
   PubMed Web of Science ®Google Scholar